Recce Pharmaceuticals Ltd Stock: price and insider trades · Australia
No insider purchase over the last 90 days. The latest, by Dr John Prendergast, was filed 06 Aug 2026.
Recce Pharmaceuticals Ltd: what insiders have been doing
Recce Pharmaceuticals Ltd belongs to the Health Care sector. Filings by its managers are published through ASX. In the past year (6 November 2025 to 6 November 2026), 2 filings came from 2 insiders.
Not one open-market sale was filed. On the buying side, 1 insider reported 1 purchase. The totals do not cover 1 filing with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 1 senior executive.
With 2 filings in twelve months, the company is quieter than the median of 5 filings across the 1,626 companies we follow on the same exchange. Over the whole record (from 2026), the tally stands at 1 purchase and no sales.
The latest purchase dates back some time: it was published 94 days ago, on 6 August 2026.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -6.5%Entry A$0.38 · Close at T+30 A$0.36
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Recce Pharmaceuticals Ltd Strong Buy (bullish), based on 1 analysts. Average price target: A$2.05.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended June 2026 · cache
- ShareASXISIN AU000000RCE5ASX:2924-03159093-6A1353978
- 37,500 shares100.0% of flowShareASXASX:2924-03118712-6A1337631Canonical exit: 29 Oct 2026 (T+90)
2 of 2 declarations
About Recce Pharmaceuticals Ltd
RCE is a company listed on the XASX market, specializing in the financial sector.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
